Aurigene.AI is a proprietary platform that blends AI algorithms with CADD methodologies to accelerate drug discovery from hit identification through to preclinical candidate selection.
It empowers scientists with data-rich insights, enabling faster go/no-go decisions and reducing the DMTA cycle by 30–40%.
ADME Bot Automation in In Vitro DMPK 
Cell Line Analysis Automation Enhancing In Vitro Biology Throughput In Vivo Bot Streamlining PK Data Processing 
NMR Reporting Automation Speeding Up MedChem Analytics 
Electronic Lab Notebook (ELN) Regulatory-Ready Scientific Recording 
R&D Datalake Unified Experimental Intelligence 
M&Q Datalake Manufacturing Data for Real-Time Action 
Galaxy-PlanX Integrated Project Management 
DocHub Smart, Centralized Documentation 
Digital QMS Agile Quality Management 
Digital LMS Workforce Learning and Compliance 
Digital Technology Transfer Scaling Process with Precision 
Cybersecurity Protecting Data, Trust, and Continuity We understand that clear communication is essential to successful collaborations, and that's why we have a dedicated team that is always ready to help you. Whether you have questions about our services, want to discuss a potential partnership, or simply want to learn more about our company, we're here to help.
Our team of experts is dedicated to providing personalised solutions tailored to your unique needs. So, please don't hesitate to reach out to us. We look forward to hearing from you and helping you achieve your business goals.
JULY 05, 2023
Artificial Intelligence (AI) is a hot topic and a technology that will revolutionize and transform industries. In pharma, AI has the potential to advance clinical research and holds great promise for transforming the process involved in drug discovery, development, manufacturing, and distribution.Indicators are the rapidly growing number of AI-enabled biologics d...
Read More
The pharmaceutical industry's journey to improve patients' health has enhanced the number of more effective HPAPIs (High Potent Active Pharmaceutical Ingredient) in development pipelines. Traditionally, HPAPIs were exclusively concomitant with oncology therapeutics. ...
Read More
Aurigene Pharmaceutical Services is a leading contract research, development and manufacturing organization which provides range of services to enable your IND/NDA filing ...
Read More
We are always looking for ways to enhance the sustainability of our products and services. Our team successfully developed a scalable manufacturing process for the API product of one of our Biotech clients using eco-friendly manufacturing technologies. Read the case study to learn more....
Read MoreAugust 28, 2020
The formal synthesis of Cladospolide-C and its analog is achieved by using enantiopure (R)-g evalerolactone 10. The significant points of this synthesis are the stereoselective dihydroxylation of a, bunsaturated ester 16 using Sharpless protocol, Wittig olefination of g evalerolactol 6 with triphenylphosphonium iodide salt 7, one pot selective oxidation ...
Read MoreJanuary 31, 2025
Drug Delivery System (DDS) has been used successfully in the past few decades to cure illnesses and enhance health because of its improved systemic circulation and ability to regulate the drug's pharmacological action. As pharmacology and pharmacokinetics advanced, the idea of controlled release emerged, demonstrating the significance of drug release in assessing...
Read MoreJanuary 31, 2025
Proteolysis-targeting chimera (PROTACs) represents a promising modality that has gained significant attention for cancer treatment. Using PROTAC technology, we synthesized novel structurally modified paullone-based PROTACs using Cereblon (CRBN) and Von Hippel–Lindau (VHL) E3 ligands....
Read MoreMarch 13, 2025
Decitabine is an anti-cancer chemotherapy drug. This article describes method development and method verification of Assay of Decitabine in tablet formulation. A new, precise, rapid, accurate RP-HPLC method has been developed for the estimation of Decitabine in pharmaceutical tablets dosage form. After optimization the good chromatographic separation was achieved...
Read MoreYou are about to leave Aurigene Pharmaceutical Services and affiliates website. Aurigene Pharmaceutical Services assumes no responsibility for the information presented on the external website or any further links from such sites. These links are presented to you only as a convenience, and the inclusion of any link does not imply endorsement by Aurigene Pharmaceutical Services.
If you wish to continue to this external website, click Proceed.
October 24th-26th, 2023 | Barcelona, Spain
Get ready to accelerate your drug’s journey to the market
Aurigene.AI
